Demand for weight-loss treatments open new markets for poppy industry

HOBART: A shortage of the weight-loss drug Ozempic to treat type 2 diabetes ... read more

Nuix pulls guidance as share price in heavy slump

MELBOURNE: Small-cap analytics company Nuix was the worst performer on the S&P/ASX 200 ... read more

Barrenjoey is now set to advise St Vincent’s Health on opportunities

SYDNEY: HMC Capital may have dropped out of Healthscope’s $1.6 billion debt stack, ... read more

Nuix slumps on late guidance withdrawal after tariff talk worries

MELBOURNE: Shares in small-cap analytics company Nuix have slumped 22 per cent to ... read more